In English? "Duh, We Don't Know", but the consumer gets screwed with their disgusting stench for Life anyway.PubMed
National Trends in
Psychiatric Not Otherwise Specified (NOS) Diagnosis and Medication Use Among
Adults in Outpatient Treatment.
Rajakannan T1, Safer DJ1, Burcu M1, Zito JM1.
·
1Dr. Rajakannan, Mr. Burcu, and Dr. Zito are with the Department of
Pharmaceutical Health Services Research, University of Maryland School of
Pharmacy, Baltimore. Dr. Zito is also with the Department of Psychiatry,
University of Maryland School of Medicine, Baltimore. Dr. Safer is with the
Department of Psychiatry and Pediatrics, Johns Hopkins University School of
Medicine, Baltimore. Send correspondence to Dr. Safer (e-mail: dsafer@jhmi.edu
).
Abstract
OBJECTIVE:
This study examined national trends between 1999
and 2010 in not otherwise specified (NOS) DSM-IV psychiatric diagnoses and in
related medication treatment patterns reported for adults during outpatient
physician office visits.
METHODS:
Data on physician office visits by adults (ages
18-64) with a psychiatric diagnosis were from the National Ambulatory Medical
Care Survey and National Hospital Ambulatory Medical Care Survey (1999-2010)
(N=52,026). Trends for visits with full-criteria diagnoses compared with visits
with NOS diagnoses were analyzed for major psychiatric diagnostic groups,
physician specialty, and prescribed medications. Population weighted chi square
and logistic regression analyses were utilized.
RESULTS:
Between 1999-2002 and 2007-2010, the proportion
of all mental health visits by adults to office-based physicians that involved
an NOS diagnosis increased significantly, from 42% to 50% (p<.001).
Significant proportional increases in NOS diagnoses included bipolar disorders
NOS (5% to 55%), anxiety disorders NOS (50% to 62%), and mood disorders NOS
(.4% to 1.8%). In 2007-2010, NOS visits accounted for a greater proportion of
visits to nonpsychiatrists than to psychiatrists (61% and 35%, respectively).
Psychotropic medications prescribed during visits increased over time for both
full-criteria and NOS diagnoses, but the increase was greater for NOS visits,
specifically for antipsychotics, anticonvulsants-mood stabilizers, and lithium.
By 2007-2010, psychotropic monotherapy and multidrug regimens were comparable
for full-criteria and NOS diagnoses.
CONCLUSIONS:
The proportion of U.S. physician visits with an
NOS psychiatric diagnosis increased to nearly 50% in 2007-2010. The increase
raises concerns about the precision of psychiatric diagnoses in community care
and about the impact on concomitant medication regimens.
But 50% is still not enough to Do anything about Stopping it.
At what point does the maggot gag?
No comments:
Post a Comment